Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionOxytocin receptor (OXTR) antagonist
Molecular Target Oxytocin receptor (OXTR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationUterine contractions
Indication DetailsInhibit uterine contractions to improve embryo implantation; Prevent preterm labor
Regulatory Designation
PartnerObsEva S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today